We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $9.16B
1-Year Est. Return 63.5%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+779.32%
AUM
$4.21B
AUM Growth
+$155M
Cap. Flow
-$92.8M
Cap. Flow %
-2.2%
Top 10 Hldgs %
20.02%
Holding
711
New
36
Increased
226
Reduced
346
Closed
34

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$45M
2
AAPL icon
Apple
AAPL
+$43.7M
3
MSFT icon
Microsoft
MSFT
+$17M
4
LAZ icon
Lazard
LAZ
+$13.5M
5
CRM icon
Salesforce
CRM
+$7.91M

Sector Composition

Rank Sector Weight
1 Technology 24.67%
2 Healthcare 14.63%
3 Industrials 11.76%
4 Communication Services 9.19%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
151
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.78M 0.16%
264,180
-11,595
-4% -$265K
NVS icon
152
Novartis
NVS
$293B
$6.71M 0.16%
77,154
+589
+0.8% +$51K
CL icon
153
Colgate-Palmolive
CL
$73.6B
$6.63M 0.16%
85,888
-290
-0.3% -$22.1K
IBB icon
154
iShares Biotechnology ETF
IBB
$9.46B
$6.5M 0.15%
47,967
-5
-0% -$678
LLY icon
155
Eli Lilly
LLY
$1.02T
$6.48M 0.15%
43,767
-1,442
-3% -$223K
BX icon
156
Blackstone
BX
$108B
$6.46M 0.15%
123,733
-5,419
-4% -$290K
LOW icon
157
Lowe's Companies
LOW
$123B
$6.26M 0.15%
37,739
-538
-1% -$82.8K
WWE
158
DELISTED
World Wrestling Entertainment
WWE
$6.25M 0.15%
154,565
-7,750
-5% -$340K
ABT icon
159
Abbott
ABT
$181B
$6.19M 0.15%
56,895
-814
-1% -$82.6K
AERI
160
DELISTED
Aerie Pharmaceuticals
AERI
$6.17M 0.15%
524,060
-13,110
-2% -$160K
LHX icon
161
L3Harris
LHX
$53B
$6.1M 0.14%
35,891
+4,890
+16% +$858K
OMC icon
162
Omnicom Group
OMC
$22.5B
$5.97M 0.14%
120,528
-1,579
-1% -$84.5K
ICPT
163
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.91M 0.14%
142,612
-5,220
-4% -$240K
PLD icon
164
Prologis
PLD
$131B
$5.88M 0.14%
58,421
-159
-0.3% -$15.9K
TFC icon
165
Truist Financial
TFC
$64.5B
$5.72M 0.14%
150,356
+11,718
+8% +$441K
TXN icon
166
Texas Instruments
TXN
$255B
$5.72M 0.14%
40,042
+2,830
+8% +$385K
VOO icon
167
Vanguard S&P 500 ETF
VOO
$1.01T
$5.68M 0.14%
18,470
-487
-3% -$148K
VO icon
168
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$5.65M 0.13%
128,188
+17,124
+15% +$746K
UCTT
169
Ultra Clean Holdings
UCTT
$3.74B
$5.64M 0.13%
262,794
-12,625
-5% -$307K
XOM icon
170
ExxonMobil
XOM
$628B
$5.64M 0.13%
164,277
-3,912
-2% -$160K
PTCT icon
171
PTC Therapeutics
PTCT
$5.77B
$5.64M 0.13%
120,626
-5,363
-4% -$264K
QCOM icon
172
Qualcomm
QCOM
$166B
$5.58M 0.13%
47,405
+187
+0.4% +$20K
SAGE
173
DELISTED
Sage Therapeutics
SAGE
$5.52M 0.13%
90,320
-3,740
-4% -$190K
CLX icon
174
Clorox
CLX
$12.5B
$5.43M 0.13%
25,826
+703
+3% +$157K
DY icon
175
Dycom Industries
DY
$12.4B
$5.36M 0.13%
101,525
+1,237
+1% +$59.9K

Similar funds

Pinnacle Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Pinnacle Associates held 711 positions worth $4.21B, up 3.8% from $4.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates's Q3 2020 filing shows 36 new, 226 increased, 346 reduced and 34 closed positions. Its largest new stake was Match Group: 359,217 shares worth $39.7M. The largest sale was People Inc, an estimated $45M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Pinnacle Associates's largest Q3 2020 buy was Match Group: 359,217 shares worth $39.7M.
  • Pinnacle Associates added most to Johnson & Johnson in Q3 2020, an estimated $14.8M increase.
  • Pinnacle Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $45M.
  • Pinnacle Associates fully exited Sphere Entertainment in Q3 2020, selling an estimated $5.43M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $4.21B portfolio in Q3 2020.
  • Pinnacle Associates opened 36 new positions and closed 34 in Q3 2020.
  • Pinnacle Associates's portfolio value rose 3.8% quarter-over-quarter to $4.21B.

Based on Pinnacle Associates's 13F filing for Q3 2020, filed 23 Oct 2020.